New Treatments for Mucositis Caused by Cancer Therapy
Author Information
Author(s): RP Symonds
Primary Institution: Beatson Oncology Centre, Western Infirmary, Glasgow, UK
Hypothesis
Can new agents effectively reduce mucositis caused by chemotherapy and radiotherapy?
Conclusion
New treatments, including granulocyte colony-stimulating factor and antibiotic pastilles, can significantly reduce mucositis and associated weight loss during cancer treatment.
Supporting Evidence
- Antibiotic pastilles reduced mucositis distribution and weight loss during treatment.
- Granulocyte colony-stimulating factor significantly reduced the incidence of mucositis in patients.
- Mechanical cleansing with saline was found to be the most effective traditional measure.
Takeaway
Mucositis is a painful side effect of cancer treatment, but new medicines can help make it less severe.
Methodology
The study involved randomized controlled trials comparing various treatments for mucositis in patients undergoing chemotherapy and radiotherapy.
Limitations
The optimal dosage and administration methods for some treatments are still not known.
Participant Demographics
Patients undergoing chemotherapy and radiotherapy for head and neck cancer.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website